Multiple sclerosis trials recruiting in Connecticut

All Multiple sclerosis trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
  NCT06433752 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Farmington, Hartford
• A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
  NCT05704361 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Connecticut: New Haven
• Exploring the Utility of [18F]3F4AP for Demyelination Imaging
  NCT06999434 · Phase: Phase 1 · Ages: 18 Years to 90 Years · Sex: All (male and female) · Connecticut: New Haven
• Identifying and Characterizing Preclinical MS
  NCT05787795 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: North Haven
• Intestinal Immunity in Neurologic Disease
  NCT06329453 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · Connecticut: North Haven
• Neurologic Stem Cell Treatment Study
  NCT02795052 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Westport
• Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
  NCT05285891 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Connecticut: New Haven
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven